Please assess the completion status of the following clinical trial:

Trial Title: China Plant Sterol Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~The key inclusion criteria will be:~* Age between 18 and 65 years old (inclusive) at baseline~* Able to provide informed consent~* Usual diet that includes significant fat consumption at the main meals eaten each week and/or a history of hypercholesterolemia~* Participant is likely to comply with the study treatment during the study period~Exclusion Criteria:~Participants will be excluded on the basis of:~* Known serious gastrointestinal disease or other serious illness. Individuals with stable cardiovascular disease will, however, be eligible~* Known lactose intolerance or diet that excludes dairy products~* Known Sitosterolaemia (a very rare genetic condition causing very high blood sitosterol levels)~* Current hospitalisation~* Current use of drug with likely significant impact on gastro-intestinal absorption of cholesterol or plant sterol (e.g. ezetimibe, bile acid-binding resins, or orlistat)~* Participant is currently using or is planning to use non-trial plant sterol/stanol-containing products for the seven week study period~* Participation in another study within last 3 months~* Pregnant or planning to become pregnant in next three months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).